20-35953838-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_033630.3(SCAND1):āc.447G>Cā(p.Glu149Asp) variant causes a missense change. The variant allele was found at a frequency of 0.0000019 in 1,582,094 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 33)
Exomes š: 0.0000014 ( 0 hom. )
Consequence
SCAND1
NM_033630.3 missense
NM_033630.3 missense
Scores
2
8
9
Clinical Significance
Conservation
PhyloP100: 4.94
Genes affected
SCAND1 (HGNC:10566): (SCAN domain containing 1) This gene encodes a SCAN box domain-containing protein. The SCAN domain is a highly conserved, leucine-rich motif of approximately 60 aa originally found within a subfamily of zinc finger proteins. This gene belongs to a family of genes that encode an isolated SCAN domain, but no zinc finger motif. This protein binds to and may regulate the function of the transcription factor myeloid zinc finger 1B. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCAND1 | NM_033630.3 | c.447G>C | p.Glu149Asp | missense_variant | 2/2 | ENST00000305978.7 | NP_361012.3 | |
SCAND1 | NM_001385710.1 | c.447G>C | p.Glu149Asp | missense_variant | 3/3 | NP_001372639.1 | ||
SCAND1 | NM_016558.4 | c.447G>C | p.Glu149Asp | missense_variant | 3/3 | NP_057642.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCAND1 | ENST00000305978.7 | c.447G>C | p.Glu149Asp | missense_variant | 2/2 | 1 | NM_033630.3 | ENSP00000301995.2 | ||
SCAND1 | ENST00000373991.3 | c.447G>C | p.Glu149Asp | missense_variant | 3/3 | 1 | ENSP00000363103.3 | |||
SCAND1 | ENST00000615116.1 | c.447G>C | p.Glu149Asp | missense_variant | 3/3 | 5 | ENSP00000481289.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152232Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
152232
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000100 AC: 2AN: 199250Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 110006
GnomAD3 exomes
AF:
AC:
2
AN:
199250
Hom.:
AF XY:
AC XY:
0
AN XY:
110006
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000140 AC: 2AN: 1429862Hom.: 0 Cov.: 33 AF XY: 0.00000141 AC XY: 1AN XY: 708884
GnomAD4 exome
AF:
AC:
2
AN:
1429862
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
708884
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152232Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74386
GnomAD4 genome
AF:
AC:
1
AN:
152232
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74386
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2023 | The c.636G>C (p.E212D) alteration is located in exon 2 (coding exon 2) of the SCAND1 gene. This alteration results from a G to C substitution at nucleotide position 636, causing the glutamic acid (E) at amino acid position 212 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;.
M_CAP
Benign
T
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L
PrimateAI
Pathogenic
T
PROVEAN
Uncertain
D;.;D
REVEL
Benign
Sift
Uncertain
D;.;D
Sift4G
Uncertain
D;D;D
Polyphen
D;D;D
Vest4
MutPred
Gain of MoRF binding (P = 0.127);Gain of MoRF binding (P = 0.127);Gain of MoRF binding (P = 0.127);
MVP
MPC
1.4
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at